Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Influenza, Human 15Neoplasms 7Leukemia, Lymphocytic, Chronic, B-Cell 5Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia 3Colorectal Neoplasms 3Neoplasms, Plasma Cell 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Hodgkin Disease 2Central Nervous System Neoplasms 2Anemia, Aplastic 2Waldenstrom Macroglobulinemia 1Vaccine-Preventable Diseases 1Vaccination Hesitancy 1Skin Neoplasms 1Sezary Syndrome 1Serology Analysis 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Patient Acceptance of Health Care 1Pancreatic Neoplasms 1

Interventions

Lenalidomide 2ofatumumab 1Trimethoprim, Sulfamethoxazole Drug Combination 1SARS-CoV-2 inactivated vaccines 1Influenza Vaccines 1Immunoglobulins 1Hizentra 1Clavulanic Acid 1Ciprofloxacin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Agammaglobulinemia × Influenza Vaccines × Clear all
NCT01924169 2018-09-20

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 7 charts
LymphoidOther hematologic neoplasm

Agammaglobulinemia, Hematologic Diseases, Influenza, Human, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡